These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26372588)

  • 1. Thrombocytosis.
    Schafer AI
    JAMA; 2015 Sep; 314(11):1171-2. PubMed ID: 26372588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombocytosis and essential thrombocythemia in childhood].
    Mialou V; Kagialis-Girard S; Galambrun C; Pondarré C; Kebaili K; Ffrench M; Pagès MP; Bertrand Y
    Arch Pediatr; 2005 Aug; 12(8):1249-54. PubMed ID: 15908186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extreme thrombocytosis in low-risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies.
    Tefferi A; Szuber N; Pardanani A; Hanson CA; Vannucchi AM; Barbui T; Gangat N
    Am J Hematol; 2021 Jun; 96(6):E182-E184. PubMed ID: 33617676
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet count in essential thrombocythemia: the more the better?
    Tefferi A
    Blood; 2008 Oct; 112(8):3526; author reply 3526-7. PubMed ID: 18840727
    [No Abstract]   [Full Text] [Related]  

  • 5. Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia.
    Mondet J; Park JH; Menard A; Marzac C; Carillo S; Pourcelot E; Girodon F; Cabagnols X; Lodé L; Socoro N; Chauvet M; Bulabois CE; Cony-Makhoul P; Corm S; Cahn JY; Mossuz P
    Haematologica; 2015 May; 100(5):e176-8. PubMed ID: 25661444
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis.
    Mignon I; Grand F; Boyer F; Hunault-Berger M; Hamel JF; Macchi L
    Am J Hematol; 2013 Dec; 88(12):1007-11. PubMed ID: 23873831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombocytosis and thrombocythemia].
    Straub W
    Schweiz Med Wochenschr; 1967 Feb; 97(8):250-3. PubMed ID: 5628323
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?
    Tefferi A; Gangat N; Wolanskyj AP
    Blood; 2006 Oct; 108(7):2493-4. PubMed ID: 16988161
    [No Abstract]   [Full Text] [Related]  

  • 9. Limb gangrene: The first sign of essential thrombocythemia.
    Bolaman AZ; Yavaşoǧlu İ
    Indian J Med Res; 2020 Apr; 151(4):380-381. PubMed ID: 32461403
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.
    Harrison CN; Butt N; Campbell P; Conneally E; Drummond M; Green AR; Murrin R; Radia DH; Mead A; Reilly JT; Cross NC; McMullin MF
    Br J Haematol; 2014 Nov; 167(3):421-3. PubMed ID: 24935860
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombocytosis and thrombocythemia.
    Mitus AJ; Schafer AI
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):157-78. PubMed ID: 2155903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
    Kabutomori O; Kanakura Y; Iwatani Y
    Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytosis and thrombocythemia.
    Schafer AI
    Blood Rev; 2001 Dec; 15(4):159-66. PubMed ID: 11792116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of Thrombocytosis: A Single-center Retrospective Study of 1,202 Patients.
    Edahiro Y; Kurokawa Y; Morishita S; Yamamoto T; Araki M; Komatsu N
    Intern Med; 2022; 61(22):3323-3328. PubMed ID: 36385045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-standing thrombocytosis often precedes thromboembolic complications heralding the diagnosis of essential thrombocythemia.
    Stalder G; Da Silva WR; Segot A; Blum S; Grandoni F; Alberio L
    Eur J Intern Med; 2023 Jan; 107():110-112. PubMed ID: 36117085
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum interleukin-6 levels in patients with thrombocytosis.
    Hollen CW; Henthorn J; Koziol JA; Burstein SA
    Leuk Lymphoma; 1992 Oct; 8(3):235-41. PubMed ID: 1490150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary and primary thrombocythemia].
    Judkiewicz L
    Acta Haematol Pol; 1993; 24(2 Suppl 1):15-20. PubMed ID: 8362612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
    Brière J
    Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled and uncontrolled thrombocytosis. Its clinical role in essential thrombocythemia.
    Lahuerta-Palacios JJ; Bornstein R; Fernández-Debora FJ; Gutiérrez-Rivas E; Ortiz MC; Larregla S; Calandre L; Montero-Castillo J
    Cancer; 1988 Mar; 61(6):1207-12. PubMed ID: 3342378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No DNA sequence copy number changes in essential thrombocythemia.
    Larramendy ML; Knuutila S; Jantunen R; Ruutu T; Juvonen E
    Cancer Genet Cytogenet; 2001 Sep; 129(2):181-2. PubMed ID: 11572227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.